
Applied DNA Announces $4.8 Million Registered Direct Offering of Common Stock
December 20th, 2017
Applied DNA Announces $4.8 Million Registered Direct Offering of Common Stock
December 20th, 2017
APDN Announces Selected Preliminary Unaudited Fiscal 4th Quarter and Year End Results
December 15th, 2017
Applied DNA to Present at the Imperial Capital 2017 Security Investor Conference on December 7 AT 9:00 AM ET
December 5th, 2017
APDN to Present at 2017 Disruptive Growth Company Showcase
September 21st, 2017
APDN Files Form S-3 Registration Statement
September 18th, 2017
Applied DNA Reports FY’17 Q3 Results
August 10th, 2017
Applied DNA Schedules Fiscal 2017 Third Quarter Financial Results Conference Call and Webcast For August 10, 2017 at 4:30 PM ET
July 27th, 2017
Applied DNA Sciences Raises $1.8 Million in Private Placement Led by Executive Officers, Board Members and Strategic Investor
June 28th, 2017
Cosmetic Industry Veteran Elizabeth Schmalz Ferguson Joins Board of Directors
May 15th, 2017